Diabetes Research Centers

Jose C Florez Jose C Florez MD PhD
Boston Area Boston Area
Dr. Florez’s research interests lie on the genetic determinants of type 2 diabetes and related metabolic traits, and how these variants may impact disease prediction and therapeutic choices. Thus his laboratory leads two parallel efforts in gene discovery and pharmacogenetics.
The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Alvin C Powers Alvin C Powers MD
Vanderbilt University Vanderbilt University
The purpose of our research is to understand how glucose stimulates insulin secretion by pancreatic islet cells and to characterize and reverse abnormalities in this process that are present in diabetes.
The Vanderbilt Diabetes Research and Training Center (DRTC), is a NIH-sponsored Diabetes Center that facilitates the discovery, application, and translation of scientific knowledge to improve the lives of people with diabetes.
Domenico Accili Domenico Accili MD
Columbia University Columbia University
The Accili laboratory studies the mechanism of insulin action and the pathogenesis of diabetes, with a focus on pancreatic beta cell failure.
The Columbia University Diabetes and Endocrinology Research Center provides research support for investigators pursuing research on diabetes and metabolic disorders.
Gerald I Shulman Gerald I Shulman MD PhD
Yale University Yale University
Dr. Shulman is the George R. Cowgill Professor of Medicine, Cellular & Molecular Physiology and Physiological Chemistry at Yale University, where he serves as Co-Director of the Yale Diabetes Research Center and Director of the Yale Mouse Metabolic Phenotyping Center.
The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Donald A McClain MD PhD Donald A McClain MD PhD
North Carolina North Carolina
My research concerns the molecular mechanisms of type 2 diabetes and the effects of iron on metabolism and risk for chronic diseases. These studies encompass basic mechanistic approaches using animal and cell culture models, as well as multicenter human clinical trials.

The mission of the North Carolina Diabetes Research Center (NCDRC) is to create and support an interactive regional diabetes research community (184 members) across four premiere research institutions in North Carolina, who currently garner over $70 million annually for support of their diabetes

Michael German MD Michael German MD
UCSF UCSF
Dr. German is the Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the the Hillblom Islet Genesis Network and the UCSF NIH Diabetes Research Center (DRC).
The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Graeme Bell Graeme Bell PhD
University of Chicago University of Chicago
Dr. Bell’s research focuses on the genetics of diabetes mellitus. Ongoing studies in his laboratory include the genetics of type 2 diabetes in the Mexican American population of Starr County, Texas.
The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders of a large and growing number of independently funded but highly interactive investigators.
Lori Sussel PhD Lori Sussel PhD
University of Colorado Denver University of Colorado Denver
The main focus of the Sussel lab is to understand the complex transcriptional networks that regulate development, differentiation and function of the pancreas. We have identified several novel regulatory pathways that are essential for islet lineage specification, normal pancreas development and the maintenance of beta cell maturation.
The University of Colorado Denver is world renowned for basic, translational, and clinical diabetes research and treatment of both Type 1 and Type 2 diabetes (T1D and T2D), and their related complications. The University of Colorado Diabetes Research Center will provide improved infrastructure and access to specialized reagents and resources, and an environment that promotes scientific interactions, research discoveries, and progress towards diabetes treatment and cures.
Kevan C Herold Kevan C Herold MD
Yale University Yale University
My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms.
The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Carmella Evans-Molina MD PhD Carmella Evans-Molina MD PhD
Indiana University Indiana University
The goals of Dr. Evans-Molina’s research program are (1) to define the molecular and inflammatory etiologies of b cell dysfunction in Type 1 and Type 2 diabetes and (2) to identify novel stem cell based strategies to improve b cell survival in diabetes.
The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.
Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.